Are patent medicine vendors effective agents in malaria control? Using lot quality assurance sampling to assess quality of practice in Jigawa, Nigeria.

  • Sima Berendes
  • , Olusegun Adeyemi
  • , Edward Adekola Oladele
  • , Olusola Bukola Oresanya
  • , Festus Okoh
  • , Joseph Valadez

Research output: Contribution to journalArticlepeer-review

25 Citations (Scopus)

Abstract

There is urgent need to regularly monitor and improve the availability and quality of malaria treatment provided by medicine sellers in Nigeria; the irrational use of antimalarials in the ACT era revealed in this study bears a high risk of economic loss, death and development of drug resistance. LQAS has been shown to be a suitable method for monitoring malaria-related indicators among PMV, and should be applied in Nigeria and elsewhere to improve service delivery.

Original languageEnglish
Article numbere44775
Pages (from-to)e44775
JournalPLoS ONE
Volume7
Issue number9
DOIs
Publication statusPublished - 1 Sept 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Are patent medicine vendors effective agents in malaria control? Using lot quality assurance sampling to assess quality of practice in Jigawa, Nigeria.'. Together they form a unique fingerprint.

Cite this